Cyclophosphamide and nandrolone decanoate in the treatment of advanced carcinoma of the breast--results of a comparative controlled trial of the agents used singly and in combination.
A random trial in which cyclophosphamide, nandrolone decanoate and the two drugs in combination were used in the treatment of advanced breast carcinoma is described. The results suggest that it is preferable to use cyclophosphamide on its own.
D000284:Administration, Oral; D000328:Adult; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D006197:Hair / Q000187:drug effects; D006204:Hair Removal; D006801:Humans; D007275:Injections, Intravenous; D007962:Leukocytes / Q000187:drug effects; D008875:Middle Aged; D009277:Nandrolone / Q000008:administration & dosage / Q000627:therapeutic use*; D014839:Vomiting / Q000139:chemically induced
D004338:Drug Combinations; D009277:Nandrolone; D003520:Cyclophosphamide